Key result
Cardiopulmonary bypass with a pump oxygenator requires bleeding reoperation in ~5% of patients.
Answers are grounded in this paper and cite their sources.
Reveals high risks of severe bleeding and acquired hemostatic defects following cardiopulmonary bypass, highlighting the complex physiological challenges of post-surgical blood management.
Patients who undergo heart surgery and cardiopulmonary bypass with a pump oxygenator are at substantial risk of serious postoperative bleeding; they often require blood-component therapy, although reoperation for bleeding is necessary for only about 1 in 20 patients. The excessive bleeding is related to both the surgical damage to blood vessels and acquired acute defects in hemostasis.1 2 3 The hemorrhagic diathesis produced by cardiopulmonary bypass has been difficult to characterize because of the complexity of the hemostatic process, the technical variations in the operative procedures, and the many uncontrolled physiologic variables associated with cardiopulmonary bypass. These variables include the effects of . . .
No takes yet. Share an insight, caveat, or question.
Laurence A. Harker (1986) conducted a review in Postoperative bleeding after heart surgery and cardiopulmonary bypass. Cardiopulmonary bypass with a pump oxygenator was evaluated on Reoperation for postoperative bleeding. Cardiopulmonary bypass with a pump oxygenator carries a substantial risk of postoperative bleeding, requiring reoperation in approximately 1 in 20 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: